Linked from

The 28 pages that link to Cirrhosis, each with the reason it gives.

• Liver transplantationRelated: Cirrhosis is a leading reason patients develop irreversible liver failure.

• ThrombocytopeniaRelated: Liver disease can contribute to thrombocytopenia through splenic sequestration and reduced thrombopoietin production.

• Liver function testsRelated: Test abnormalities may be modest even when chronic structural disease is advanced.

• AlbuminRelated: Impaired synthesis in cirrhosis commonly lowers blood albumin concentration.

• AscitesRelated: It is the leading cause of ascites in many settings through portal hypertension and sodium retention.

• HepatocyteRelated: Chronic hepatocyte injury and repair can drive the scarring that defines cirrhosis.

• Hepatic encephalopathyRelated: It is a common underlying condition when hepatic encephalopathy develops.

• Hepatocellular carcinomaRelated: Most cases develop in livers already damaged by cirrhosis.

• HepatotoxicityRelated: Repeated or persistent toxic injury can contribute to progressive scarring.

• Portal hypertensionRelated: It is the most common cause of portal hypertension in many populations.

• Wilson's diseaseRelated: Long-standing copper-related liver injury can progress to cirrhosis.

• Hepatitis B virusRelated: Chronic HBV can drive fibrosis that progresses to cirrhosis and liver failure.

• Iron overloadRelated: Long-standing hepatic iron deposition can contribute to fibrosis and cirrhosis.

• Autoimmune hepatitisRelated: Untreated or inadequately controlled disease may progress to cirrhosis.

• HepatitisRelated: Chronic hepatitis can progress to this severe form of scarring.

• Hepatitis C virusRelated: Long-standing hepatitis C can progressively scar the liver and lead to cirrhosis.

• Hepatitis ERelated: Persistent HEV can accelerate liver damage in transplant recipients and others with chronic liver disease.

• Hepatitis DRelated: Chronic hepatitis D can accelerate the development of cirrhosis.

• Liver cancerRelated: It creates a major risk setting for hepatocellular carcinoma.

• Biliary atresiaRelated: Untreated or progressive disease can culminate in cirrhosis despite restored bile drainage.

• AnasarcaRelated: It can promote anasarca through low albumin, portal hypertension, and sodium retention.